Related Experiment Video

Updated: Mar 16, 2026

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

2.0K

Current Status of Immunotherapy Treatments for Pancreatic Cancer

Cristina Jimenez-Luna1, Jose Prados, Raul Ortiz

  • 1*Institute of Biopathology and Regenerative Medicine (IBIMER) ‡Department of Biochemistry and Molecular Biology I, Universidad de Granada, Granada †Department of Health Sciences, Universidad de Jaen, Jaen, Spain.

Journal of Clinical Gastroenterology
|August 10, 2016
PubMed

Insights

Pancreatic cancer (PC) remains a deadly disease with poor survival rates. Immunotherapy offers a promising new avenue for treatment, with ongoing research and clinical trials showing encouraging results for patients.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Pancreatic cancer (PC) is a leading cause of cancer mortality globally.
  • Tumor resistance to existing therapies results in poor patient survival rates.
  • Novel and effective treatment strategies for PC are critically needed.

Purpose of the Study:

  • To review recent advancements in immunotherapy for pancreatic cancer.
  • To summarize key findings from preclinical and clinical studies.
  • To provide an overview of current and emerging immunotherapeutic approaches for PC treatment.

Main Methods:

  • Literature review of preclinical research.
  • Analysis of data from recent clinical trials.
  • Synthesis of current knowledge on pancreatic cancer immunotherapy.

Main Results:

  • Immunotherapy has emerged as a promising treatment modality for PC.
  • Encouraging results have been reported in various preclinical and clinical investigations.
  • Ongoing studies are exploring novel immunotherapeutic strategies for PC.

Conclusions:

  • Immunotherapy holds significant potential for improving outcomes in pancreatic cancer.
  • Further research and clinical trials are essential to optimize immunotherapeutic regimens.
  • This review highlights the evolving landscape of PC treatment through immunotherapy.

More Related Videos

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.6K
Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

12.4K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
457
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K